Vioxx risks could have been identified years earlier

The significant cardiovascular risks linked to Vioxx could have been identified nearly four years before the anti-inflammatory medication was taken off the market, a new study has concluded, but consumers and physicians didn't have access to such information at the time.

By Shari Roan

November 24, 2009